Roderick j. Flower

Roderick j. Flower's AcademicInfluence.com Rankings

Roderick j. Flower

Medical

#949

World Rank

#1223

Historical Rank

Pharmacology

#65

World Rank

#86

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Roderick j. Flower Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roderick j. Flower's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. (1993) (1596)
Drugs which inhibit prostaglandin biosynthesis. (1974) (1324)
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. (1976) (997)
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids (1980) (877)
Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation (1979) (876)
The electronic aggregometer: a novel device for assessing platelet behavior in blood. (1980) (731)
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis (2009) (632)
The importance of phospholipase-A2 in prostaglandin biosynthesis. (1976) (597)
Lipocortin and the mechanism of action of the glucocorticoids (1988) (493)
A new approach to anti-inflammatory drugs. (1979) (464)
Effects of anti-inflammatory drugs on prostaglandin biosynthesis. (1972) (459)
Inhibition of prostaglandin biosynthesis. (1974) (386)
Lipocortin-1: cellular mechanisms and clinical relevance. (1994) (380)
The development of COX2 inhibitors (2003) (375)
Aberrant inflammation and resistance to glucocorticoids in Annexin 1−/− Mouse (2003) (369)
Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. (1999) (321)
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism (2000) (319)
Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation (2010) (292)
Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. (1978) (292)
Inhibition of poly (ADP-ribose) Synthetase Attenuates Neutrophil Recruitment and Exerts Antiinflammatory Effects (1997) (283)
Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle. (1973) (266)
Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses (2013) (252)
Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration (1996) (242)
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. (2006) (236)
Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. (1993) (233)
Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci: Receptor-Dependent Actions (2012) (214)
Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. (2003) (211)
Anti-phospholipase proteins. (1984) (202)
Endogenous monocyte chemoattractant protein‐1 recruits monocytes in the zymosan peritonitis model (1998) (201)
GLUCOCORTICOIDS INDUCE THE FORMATION AND RELEASE OF ANTI‐INFLAMMATORY AND ANTI‐PHOSPHOLIPASE PROTEINS INTO THE PERITONEAL CAVITY OF THE RAT (1982) (197)
Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. (1989) (191)
History of Aspirin and Its Mechanism of Action (1990) (188)
Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. (1998) (188)
Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. (2003) (188)
Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone (1990) (187)
Cutting Edge: Humanized Nano-Proresolving Medicines Mimic Inflammation-Resolution and Enhance Wound Healing (2011) (183)
Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. (2002) (177)
Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. (2004) (175)
Annexin‐A1: a pivotal regulator of the innate and adaptive immune systems (2008) (172)
Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. (1993) (169)
Annexin-1 modulates T-cell activation and differentiation. (2007) (157)
Extraction and thin-layer chromatography of arachidonic acid metabolites. (1982) (156)
Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung (1987) (155)
Annexin 1 and the biology of the neutrophil (2004) (151)
Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells (2002) (146)
Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. (1995) (145)
Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1 (1997) (142)
Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. (1992) (139)
POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. (1999) (136)
Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. (2005) (135)
1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. (1978) (133)
Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. (1995) (133)
Arachidonic acid 15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes. Partial purification and properties. (1981) (131)
Annexin 1 peptides protect against experimental myocardial ischemia‐reperfusion: analysis of their mechanism of action (2001) (129)
Annexin 1 Cleavage in Activated Neutrophils (2007) (128)
Annexin 1‐deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro (2005) (126)
Further characterization of the glucocorticoid-induced antiphospholipase protein "renocortin". (1983) (126)
ANNEXIN I IS STORED WITHIN GELATINASE GRANULES OF HUMAN NEUTROPHIL AND MOBILIZED ON THE CELL SURFACE UPON ADHESION BUT NOT PHAGOCYTOSIS (2000) (124)
Synthesis of 6-keto-PGF1a by ram seminal vesicle microsomes (1977) (123)
Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids (1976) (123)
Role of lipocortin‐1 in the anti‐hyperalgesic actions of dexamethasone (1997) (122)
Inhibition of phospholipase. (1983) (120)
Activation of the annexin 1 counter‐regulatory circuit affords protection in the mouse brain microcirculation (2007) (119)
Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. (1982) (116)
Glucocorticoid — and non‐glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo (1993) (111)
Effect of aspirin on human seminal prostaglandins. (1971) (109)
Post‐translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface (2006) (107)
Effects of intravenous infusion of prostacyclin (PGI2) in man. (1980) (106)
Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. (1995) (105)
Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism (1976) (105)
Annexin A1 Interaction with the FPR2/ALX Receptor (2012) (104)
Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. (2001) (103)
Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis (2014) (103)
Ligand-specific glucocorticoid receptor activation in human platelets. (2005) (100)
Annexin A1 Regulates Intestinal Mucosal Injury, Inflammation, and Repair1 (2008) (95)
Prostaglandins and related compounds. (1977) (94)
Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation (1996) (92)
Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes. (1975) (91)
Redundancy of a Functional Melanocortin 1 Receptor in the Anti-inflammatory Actions of Melanocortin Peptides: Studies in the Recessive Yellow (e/e) Mouse Suggest an Important Role for Melanocortin 3 Receptor1 (2003) (90)
An overview of the effects of annexin 1 on cells involved in the inflammatory process. (2005) (88)
The annexin-1 knockout mouse: what it tells us about the inflammatory response. (2002) (88)
A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. (2013) (87)
Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins. (1997) (87)
IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. (1998) (86)
Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. (1996) (85)
Lifestyle drugs: pharmacology and the social agenda. (2004) (83)
Impaired T cell activation and increased Th2 lineage commitment in Annexin‐1‐deficient T cells (2007) (82)
A study of phospholipase A2-induced oedema in rat paw. (1989) (81)
Annexin 1, Glucocorticoids, and the Neuroendocrine–Immune Interface (2006) (80)
Natural and synthetic agonists of the melanocortin receptor type 3 possess anti‐inflammatory properties (2001) (79)
Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation. (1990) (78)
Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. (1998) (78)
Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. (1993) (78)
Annexin 1 and the regulation of endocrine function (2004) (77)
Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis (2002) (77)
Anti‐inflammatory actions of an N‐terminal peptide from human lipocortin 1 (1993) (75)
Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids (changed from glucorticoids) inhibit G protein-dependent activation of cPLA2 activity. (1995) (74)
Anti-inflammatory and immunosuppressant drugs (2007) (72)
Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. (2009) (71)
Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells. (1994) (71)
Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of Peritonitis1 (2006) (69)
Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation. (1996) (69)
Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. (1997) (68)
Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis. (1997) (68)
Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action. (1997) (68)
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice (2002) (67)
Antipyretic actions of human recombinant lipocortin‐1 (1991) (67)
The assay of endogenous cholecystokinin and factors influencing its release in the dog and cat. (1971) (67)
Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. (1985) (66)
A Novel Effect for Annexin 1-Derived Peptide Ac2-26: Reduction of Allergic Inflammation in the Rat (2005) (65)
Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1 (2001) (65)
Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. (1989) (65)
Glucocorticoid Receptor Nitration Leads to Enhanced Anti-Inflammatory Effects of Novel Steroid Ligands 1 (2003) (64)
Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1 (1996) (62)
Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC (1999) (62)
Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. (1984) (62)
Annexin-1 modulates repair of gastric mucosal injury. (2008) (61)
Attenuation of glucocorticoid functions in an Anx-A1-/- cell line. (2003) (61)
Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro. (1987) (59)
Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice (2015) (59)
Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of Peritonitis (2006) (59)
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword? (2007) (59)
Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus. (1995) (59)
Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation (2015) (58)
21‐NO‐prednisolone is a novel nitric oxide‐releasing derivative of prednisolone with enhanced anti‐inflammatory properties (2000) (58)
Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1. (1995) (58)
Characterization and localization of lipocortin 1-binding sites on rat anterior pituitary cells by fluorescence-activated cell analysis/sorting and electron microscopy. (1997) (57)
Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms. (1995) (57)
Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1 (2009) (57)
Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. (1999) (57)
Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: focus on neutrophil recruitment. (2001) (55)
Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release? (1993) (55)
A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment (1997) (54)
THE INHIBITION BY HYDROCORTISONE OF PROSTAGLANDIN BIOSYNTHESIS IN RAT PERITONEAL LEUCOCYTES IS CORRELATED WITH INTRACELLULAR MACROCORTIN LEVELS (1981) (54)
Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-d-aspartate (NMDA) receptor activation (2007) (53)
Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro (1997) (53)
Evidence for an Anti-Inflammatory Loop Centered on Polymorphonuclear Leukocyte Formyl Peptide Receptor 2/Lipoxin A4 Receptor and Operative in the Inflamed Microvasculature (2011) (52)
The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. (1989) (51)
An Immunocytochemical and In Situ Hybridization Analysis of Annexin 1 Expression in Rat Mast Cells: Modulation by Inflammation and Dexamethasone (2000) (51)
Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation (2014) (50)
Impaired phagocytic mechanism in annexin 1 null macrophages (2006) (49)
Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. (2008) (49)
Serum corticosterone, interleukin‐1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strains (1993) (48)
What are all the things that aspirin does? (2003) (48)
Annexin‐1‐deficient dendritic cells acquire a mature phenotype during differentiation (2009) (48)
Attenuation of plasma annexin A1 in human obesity (2013) (48)
Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. (2002) (48)
The concerted regulation of cPLA2, COX2, and lipocortin 1 expression by IL-1beta in A549 cells. (1996) (48)
Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis (1992) (47)
The local anti‐inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1 (1993) (47)
Functional importance of the dihydropyridine‐sensitive, yet voltage‐insensitive store‐operated Ca2+ influx of U937 cells (1996) (46)
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis (2011) (46)
An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. (1997) (46)
Prostacyclin is produced in whole blood [proceedings]. (1978) (45)
Lipocortin 1 (annexin 1) in patches associated with the membrane of a lung adenocarcinoma cell line and in the cell cytoplasm. (1998) (44)
Kinase‐Dependent Regulation of the Secretion of Thyrotrophin and Luteinizing Hormone By Glucocorticoids and Annexin 1 Peptides (2003) (44)
The role of lipocortin in corticosteroid actions. (1990) (44)
N‐terminal peptide fragments of lipocortin‐1 inhibit a549 cell growth and block EGF‐induced stimulation of proliferation (1993) (44)
Stimulus‐specific defect in the phagocytic pathways of annexin 1 null macrophages (2004) (43)
Steroidal antiinflammatory drugs as inhibitors of phospholipase A2. (1978) (42)
Seminal prostaglandins in infertile men. (1975) (42)
Glucocorticoids, phospholipase A2 and inflammation (1981) (42)
Dexamethasone suppression of IL-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells. (1994) (41)
Cytokines, glucocorticoids and neuroendocrine function. (1994) (41)
Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis. (1992) (40)
Antiallergic Cromones Inhibit Neutrophil Recruitment Onto Vascular Endothelium via Annexin-A1 Mobilization (2010) (40)
A role for endogenous histamine in interleukin‐8‐induced neutrophil infiltration into mouse air‐pouch: investigation of the modulatory action of systemic and local dexamethasone (1994) (40)
Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization (2009) (40)
Effects of Lipocortin 1 and Dexamethasone on the Secretion of Corticotrophin‐Releasing Factors in the Rat: in vitro and in vivo Studies (1993) (39)
Medicine: Lipid signals in pain control (2002) (39)
Measuring platelet and leucocyte aggregation/adhesion responses in very small volumes of whole blood. (1981) (39)
Immunoneutralization of lipocortin 1 reverses the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat in vitro and in vivo. (1995) (39)
Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3',5'-monophosphate-stimulated prolactin secretion. (2000) (39)
Macrocortin and the antiphospholipase proteins (1984) (38)
Increased susceptibility of annexin‐A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin‐A1 (2008) (38)
The detection of lipocortins 1, 2 and 5 in central nervous system tissues from Lewis rats with acute experimental allergic encephalomyelitis (1990) (37)
Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity. (1994) (37)
Resident mast cells are important for eotaxin‐induced eosinophil accumulation in vivo (1998) (37)
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1 (2009) (37)
Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides (2007) (36)
Cytokines, glucocorticoids and lipocortins in the control of neutrophil migration. (1994) (36)
Antisense oligonucleotides to human lipocortin-1 inhibit glucocorticoid-induced inhibition of A549 cell growth and eicosanoid release. (1994) (35)
Inhibitory effect of peptides derived from the N‐terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: identification of E‐Q‐E‐Y‐V as a crucial component (1998) (35)
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. (1983) (35)
Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide. (1995) (35)
Differential modulation of annexin I binding sites on monocytes and neutrophils. (1999) (35)
Reversal of the anti-inflammatory effects of dexamethasone by the glucocorticoid antagonist RU 38486. (1988) (35)
Dysfunctional Skin-Derived Glucocorticoid Synthesis Is a Pathogenic Mechanism of Psoriasis. (2017) (34)
Blockade of the classical pathway of protein secretion does not affect the cellular exportation of lipocortin 1 (1998) (34)
Anti-Allergic Cromones Inhibit Histamine and Eicosanoid Release from Activated Human and Murine Mast Cells by Releasing Annexin A1 (2013) (33)
Studies on the roles of phospholipase A2 and eicosanoids in the regulation of corticotrophin secretion by rat pituitary cells in vitro. (1991) (33)
Modulation of cellular annexin I in human leukocytes infiltrating DTH skin reactions (1999) (33)
Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo: a possible role for lipocortin 1. (1998) (33)
The ability of murine leukocytes to bind lipocortin 1 is lost during acute inflammation. (1993) (32)
Glucocorticoid receptor activation reduces CD11b and CD49d levels on murine eosinophils: characterization and functional relevance. (2000) (32)
Controlling inflammation (2005) (31)
Inflammation: The mediators of steroid action (1986) (31)
Drug discovery and development (2007) (31)
Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I). (2000) (31)
Mast cells mediate early neutrophil recruitment and exhibit anti‐inflammatory properties via the formyl peptide receptor 2/lipoxin A4 receptor (2017) (31)
Investigation of the functional role played by the chemokine monocyte chemoattractant protein‐1 in interleukin‐1‐induced murine peritonitis (1998) (30)
What is pharmacology (2007) (30)
Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue. (2006) (30)
Relative contribution of the selectins in the neutrophil recruitment caused by the chemokine cytokine-induced neutrophil chemoattractant (CINC). (1996) (30)
Annexin-A1 restricts Th17 cells and attenuates the severity of autoimmune disease. (2015) (30)
Subacute treatment of rats with dexamethasone reduces ICAM-1 levels on circulating monocytes. (1997) (29)
Targeting the melanocortin receptor system for anti-stroke therapy. (2011) (29)
Contrasting roles for RANTES and macrophage inflammatory protein‐1α (MIP‐1α) in a murine model of allergic peritonitis (1999) (28)
Anxiolytic and hypnotic drugs (2007) (28)
Identification of benzopyrone as a common structural feature in compounds with anti-inflammatory activity in a zebrafish phenotypic screen (2016) (28)
Opposing influences of glucocorticoids and interleukin‐1β on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1 (2001) (27)
Antiflammin-2 Activates the Human Formyl-Peptide Receptor Like 1 (2006) (26)
Investigation into the involvement of phospholipases A2 and MAP kinases in modulation of AA release and cell growth in A549 cells (2000) (26)
Lipocortin-1 distribution in bronchoalveolar lavage from healthy human lung: effect of prednisolone. (1995) (26)
Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system (2003) (26)
Dexamethasone inhibits leukocyte emigration in rat mesenteric post‐capillary venules: an intravital microscopy study (1997) (25)
Hydrocortisone induces lipocortin 1 production by peripheral blood mononuclear cells in vivo in man. (1990) (25)
Evidence for the presence and location of annexins in human platelets. (1992) (24)
Lack of Annexin 1 Results in an Increase in Corticotroph Number in Male but not Female Mice (2006) (24)
Generation of innovative anti-inflammatory and anti-arthritic glucocorticoid derivatives that release NO: the nitro-steroids. (2003) (24)
Paracetamol-Induced Hypothermia Is Independent of Cannabinoids and Transient Receptor Potential Vanilloid-1 and Is Not Mediated by AM404 (2011) (23)
The role of prostaglandins in parturition, with special reference to the rat. (1977) (23)
Role of endogenous Annexin-A1 in the regulation of thymocyte positive and negative selection (2010) (23)
Benzolamide improves oxygenation and reduces acute mountain sickness during a high‐altitude trek and has fewer side effects than acetazolamide at sea level (2016) (22)
Modulation of ICAM-1 levels on U-937 cells and mouse macrophages by interleukin-1 beta and dexamethasone. (1996) (22)
Metabolism and transfer of choline in hamster small intestine (1972) (22)
Lipocortin 1 (annexin 1) immunoreactivity in the cervical spinal cord of Lewis rats with acute experimental allergic encephalomyelitis (1993) (22)
Topical glucocorticoids inhibit neurogenic inflammation: involvement of lipocortin 1. (1995) (22)
The role of the Annexin-A1/FPR2 system in the regulation of mast cell degranulation provoked by compound 48/80 and in the inhibitory action of nedocromil (2016) (19)
The Anti-allergic Cromones: Past, Present, and Future (2017) (19)
Role of annexin 1 gene expression in mouse craniofacial bone development. (2007) (19)
Corrections: Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation (2011) (19)
Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system. (2012) (19)
DIPYRIDAMOLE AND PLATELET FUNCTION (1978) (18)
Background and discovery of lipocortins (2005) (18)
The respiratory system (2007) (18)
Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1) (2000) (18)
Phospholipases and their Relevance to Prostaglandin Biosynthesis (1981) (18)
From NSAIDs to Glucocorticoids and Beyond (2021) (17)
Pharmacology of interleukin-1-induced neutrophil migration (2005) (17)
The study of platelet aggregation in whole blood [proceedings]. (1979) (17)
Letter: Reduction of the inflammatory response in rats immunized against prostaglandins. (1974) (17)
How drugs act: general principles (2007) (16)
An assay for the assessment of lipocortin 1 levels in human lung lavage fluid. (1990) (16)
The role of lipocortin 1 in the regulation of A549 cell proliferation and leukocyte migration. (1993) (16)
Chemical transmission and drug action in the central nervous system (2007) (15)
Induction of lipocortin 1 by topical steroid in rat skin. (1994) (15)
Absorption and distribution of drugs (2007) (15)
Lipocortin-1 exhibits novel actions, providing clinical opportunities. (1992) (15)
Lipocortin 1 co-associates with cytokeratins 8 and 18 in A549 cells via the N-terminal domain. (1998) (15)
Annexin A1 modulates macula densa function by inhibiting cyclooxygenase 2. (2012) (15)
Agonism at melanocortin receptor type 3 on macrophages inhibits neutrophil influx (1999) (15)
Atherosclerosis and lipoprotein metabolism (2007) (15)
Endogenous corticosteroids modulate lymphoproliferation and susceptibility to experimental allergic encephalomyelitis in the Brown Norway rat. (1995) (15)
Endogenous corticosteroids mediate the neutrophilia caused by platelet-activating factor in the mouse. (1995) (14)
1-n-Butylimidazole: a potent and selective inhibitor of 'thromboxane synthetase' [proceedings]. (1978) (14)
Phospholipase A2-induced stimulation of A549 lung adenocarcinoma cell line proliferation. (1993) (14)
Studies on the mechanism of action of anti-inflammatory drugs. A paper in honour of John Vane. (2003) (14)
The annexin 1-/- mouse: phenotypic studies (2004) (13)
Endogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions (2019) (13)
Aspirin, prostaglandins, endoperoxides and platelets (1975) (13)
Biochemistry of prostaglandins. (1978) (13)
Anti-allergic drugs and the Annexin-A1 system. (2010) (13)
Circulating autoantibodies to recombinant lipocortin-1 in asthma. (1991) (13)
Differential role of extra- and intracellular calcium in bradykinin and interleukin 1 alpha stimulation of arachidonic acid release from A549 cells. (1994) (12)
The mediators of steroid action. (1986) (12)
The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS). (2008) (12)
843 - REDUCTION OF LEUKOCYTE MIGRATION BY A CYCLO-OXYGENASE AND LIPOXYGENASE INHIBITOR (1978) (11)
[14] Preparation and assay of prostacyclin synthase (1982) (11)
Identification of a Novel Recycling Sequence in the C-tail of FPR2/ALX Receptor (2014) (11)
Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells. (1997) (11)
Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis. (1999) (11)
Magnetically responsive layer-by-layer microcapsules can be retained in cells and under flow conditions to promote local drug release without triggering ROS production. (2020) (11)
Mechanism of steroid induced inhibition of arachidonate oxidation (1981) (11)
The vascular system (2007) (10)
Site of anti-inflammatory action of dexamethasone in rabbit skin. (1991) (10)
How drugs act: molecular aspects (2007) (10)
Glucocorticoid biology — a molecular maze and clinical challenge (2001) (10)
Non-steroidal anti-inflammatory drugs: back to the future. (1999) (10)
ON THE PREPARATION OF HIGHLY PURIFIED SLOW REACTING SUBSTANCE OF ANAPHYLAXIS (SRS‐A) FROM BIOLOGICAL EXTRACTS (1980) (10)
Annexin-A1 gene expression during liver development and post-translation modification after experimental endotoxemia (2008) (10)
Steroidal Anti-Inflammatory Drugs (1981) (10)
Haemostasis and thrombosis (2007) (10)
The co-ordinate regulation of lipocortin 1, COX 2 and cPLA2 by IL-1 beta in A549 cells. (1997) (9)
Annexin A 1 Regulates Intestinal Mucosal Injury , Inflammation , and Repair 1 (2008) (9)
Localization of lipocortin-1 in rat hypothalamus and pituitary gland. (1990) (9)
Macrophage biology in the Anx-A1-/- mouse. (2005) (9)
The pituitary and the adrenal cortex (2007) (9)
Spite, M. et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291 (2009) (8)
Loss of hypothermic and anti-pyretic action of paracetamol in cyclooxygenase-1 knockout mice is indicative of inhibition of cyclooxygenase-1 variant enzymes. (2019) (8)
General Anaesthetic Agents (2007) (8)
The control of blood glucose and drug treatment of diabetes mellitus (2012) (8)
Effect of endotoxin on 15-hydroxyprostaglandin dehydrogenase in the rabbit jejunum and lung. (1976) (8)
The Generation of Lyso-PAF in Experimental Inflammation (1985) (8)
Endogenous annexin A 1 counter-regulates bleomycin-induced lung fibrosis (2011) (8)
Aspirin-like drugs and prostaglandins. (1973) (8)
The presence of autoantibody to recombinant lipocortin‐I in patients with psoriasis and psoriatic arthritis (1990) (8)
The metabolite formed during choline transfer by the intestine. (1972) (7)
Investigation into the involvement of phospholipases A2 and map kinases in modulation of AA release and cell growth in A549 cells. (1999) (7)
Chemical mediators and the autonomic nervous system (2007) (7)
The reproductive system (2007) (7)
Dexamethasone reduces cell surface levels of CD11b on human eosinophils (1997) (7)
A RAPID METHOD FOR THE ESTIMATION OF PROSTAGLANDIN 15‐HYDROXYDEHYDROGENASE ACTIVITY AND ITS APPLICATION TO PHARMACOLOGY (1976) (7)
Anti-inflammatory lipocortin-derived peptides. (1995) (7)
A novel binding assay for phospholipase A2. (1987) (7)
CNS stimulants and psychotomimetic drugs (2007) (7)
The 'electronic platelet aggregometer' [proceedings]. (1979) (6)
Drug addiction, dependence and abuse (2007) (6)
The role of prostaglandins in inflammatory reactions (2004) (6)
Local anaesthetics and other drugs affecting sodium channels (2007) (6)
Proceedings: Inhibition of the pulmonary inactivation of prostaglandins in rabbit in vivo. (1975) (6)
Identification of the 37kda Annexin-A1 Protein in Tears of Normal Subjects and Association of its 33kda Inactive Form with Active Vernal Keratoconjunctivitis Patients (2012) (6)
Glucocorticosteroids in Asthma (1991) (6)
Skin Wound Repair Is Not Altered in the Absence of Endogenous AnxA1 or AnxA5, but Pharmacological Concentrations of AnxA4 and AnxA5 Inhibit Wound Hemostasis (2016) (6)
Biopharmaceuticals and gene therapy (2007) (5)
Drug receptors: A long engagement (2002) (5)
Purification and properties of arachidonate-15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes. (1982) (5)
Amino acid transmitters (2007) (5)
Too soon for consensus? (1990) (5)
Harmful effects of drugs (2007) (5)
Development of specific antibody andin vivo response to antigen in different rat strains: Effect of dexamethasone and importance of endogenous corticosteroids (1993) (5)
Proceedings: Effects of steriod hormones on tissue levels of prostaglandin 15-hydroxydehydrogenase in the rat. (1976) (5)
Some properties of rabbit aorta contracting substance-releasing factor (RCS-RF) [proceedings]. (1976) (5)
Glucocorticoid-Induced Anti-Phospholipase Proteins (1985) (5)
The lipocortins and their role in controlling defense reactions. (1985) (5)
Peptide 204-212 of lipocortin 5 inhibits the generation of a prostacyclin-like factor from rat aorta preparations in vitro. (1992) (5)
Preparation and assay of prostacyclin synthase. (1982) (5)
Other transmitters and modulators (2007) (5)
Basic Biochemistry of Prostaglandin Metabolism with Especial Reference to PGDH (1981) (4)
The outsider: the rogue scientist as terrorist (2013) (4)
Limits Polymorphonuclear Leukocytes Recruitment to Inflammatory Loci Receptor-Dependent Actions (2012) (4)
Factors influencing the turnover of prostaglandin synthetase. (1975) (4)
The Osler Lecture 2012: 'pharmacology 2.0, medicines, drugs and human enhancement'. (2012) (4)
‘Annexins’ themed section (2015) (4)
Obituary: : Sir John Vane FRS (2005) (4)
1-Phenyl-3-pyrazolidone: an inhibitor of arachidonate oxidation in lung and platelets [proceedings]. (1978) (4)
Important Role for Melanocortin 3 Receptor Recessive Yellow ( e / e ) Mouse Suggest an Melanocortin Peptides : Studies in the ofReceptor in the Anti-inflammatory Actions Redundancy of a Functional Melanocortin 1 and Mauro Perretti (2003) (4)
New directions in cyclooxygenase research and their implications for NSAID-gastropathy. (1996) (4)
A Comparative Evaluation of the Response to Peroxynitrite by a Brain Endothelial Cell Line and Control of the Effects by Drug Targeting (2009) (4)
Oiling the wheels of discovery (2019) (4)
Method and measurement in pharmacology (2007) (4)
Biosynthesis of prostaglandins. (1978) (4)
Flow cytometric detection of lipocortin 1 binding sites on rat anterior pituitary cells (1995) (4)
A Possible Anti-Inflammatory Mechanism for Glucocorticoids in the Human Lung (1989) (4)
Eicosanoids: the nobel prize (1983) (4)
Regulation of pulmonary arachidonic acid metabolism by anti-inflammatory steroids. (1980) (3)
Lifestyle drugs and drugs in sport (2007) (3)
How drugs act: cellular aspects—excitation, contraction and secretion (2007) (3)
Novel method for the detection and estimation of intracellular lipocortin 1 in the anterior pituitary gland by FAC-analysis/sorting (1997) (3)
Salivary cortisol: a possible regulator of salivary annexin 1 (2008) (3)
Anti-inflammatory glucocorticoids and annexin 1 (2008) (3)
Drug absorption and distribution (2012) (3)
Evidence for different molecular species of lipocortin 1 in the rat (1995) (3)
678 – MECHANISM OF COLLAGEN INDUCED PLATELET AGGREGATION (1977) (3)
Detection of lipocortin 1 (LC1) and LC1 binding sites in the rat anterior pituitary gland by fluorescent activated cell analysis/sorting (FACS) (1996) (3)
Resolvin D1 limits PMN recruitment to inflammatory loci: receptor dependent bioactions (2012) (3)
Glucocorticoids, lungs and prostaglandins. (1981) (2)
The Role of Lipocortin 1 (LC1) in the Steroid Feedback Control of Hypothalamo‐Pituitary‐Adrenocortical Function. In Vivo Studies a (1994) (2)
Cell proliferation, apoptosis, repair and regeneration (2012) (2)
Proceedings: Possible contribution of prostaglandins to genetic hypertension in rats: identification of biochemical lesion. (1975) (2)
Proceedings: Prostaglandin D1 inhibits the increase in vascular permeability in rat skin produced by prostaglandin E1, E2 and D2. (1975) (2)
Effects on Leukocyte Responses and Formyl-Peptide Receptor 2 : Ligand-Specific Anti-Inflammatory Role of the Murine (2010) (2)
Chapter 25 – Annexin A1 (2017) (2)
Individual variation and drug interaction (2007) (2)
The Anti-Inflammatory Activity of Human Recombinant Lipocortin 1 (1991) (2)
Anti-inflammatory Drugs: History and mechanism of action (1990) (2)
Complete coding sequence of equine inducible nitric oxide synthase. (2002) (2)
Phospholipase A2 activity of guinea-pig perfused lungs: stimulation and inhibition by anti-inflammatory steroids [proceedings]. (1977) (2)
A simple isotope derivative assay for prostaglandins and prostaglandin metabolites. I. Assay of e-type prostaglandins. (1975) (2)
Synthesis of 6-keto-PGF1alpha by ram seminal vesicle microsomes. (1977) (2)
The epidemiology of NSAIDs (1998) (2)
Pharmacology 2.0. (2013) (1)
Drug metabolism and elimination (2012) (1)
Biosynthesis of Prostaglandins and Inhibition of Biosynthesis by Aspirin-Like Drugs (1974) (1)
Identification of The Anti-Inflammatory Annexin-A1 Protein in Tears of Normal Subjects and Association of its Cleaved-Inactive Form with Active Vernal Keratoconjunctivitis Patients (2012) (1)
Lipocortin 1 and Hypothalamo‐Pituitary Function in the Rat a (1994) (1)
The effect of glucocorticoids on lyso-PAF formationin vitro andin vivo (2005) (1)
Wither the beauty's transient flower (1992) (1)
Haemopoietic system and treatment of anaemia (2012) (1)
Lipocortin: what is it and what does it mean? (1992) (1)
The effect of bradykinin on the electrical activity of rat jejunum (1978) (1)
OP06 Annexin A1 (AnxA1) mediates hydrogen sulfide (H2S) effects in the control of inflammation (2013) (1)
Gustav Victor Rudolph Born. 29 July 1921—16 April 2018 (2020) (1)
Expression and localisation of lipocortin 1 in the rat adrenal gland (1999) (1)
THE DISCOVERY OF PROSTAGLANDINS (2011) (1)
A novel role for Annexin 1 in macrophage phagocytosis (2005) (1)
Glucocorticoids and lipocortin (1992) (1)
Animal experiments and the doctor. (2002) (1)
The man who knew doses (2000) (1)
Salivary annexin 1 has a diurnal rhythm but does not share an awakening response with cortisol at 30 min (2010) (1)
Of platelets and aggregometers: personal reminiscences of Gus Born (1921–2018) (2018) (1)
anti-inflammatory mechanisms Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related (2013) (1)
Annexin-A1 Peptide Ac2–26 (2013) (1)
Immunohistochemical localisation of lipocortin (annexin) 1 expression in the central nervous system of Lewis rats with experimental allergic encephalomyelitis (1993) (1)
Lipocortin 1 (Annexin 1) (2002) (1)
Physiological Reactions of Arachidonic Acid Oxygenation Products (1983) (1)
Proceedings: Prostaglandins and intestinal function. (1974) (1)
Sexual dimorphism in anterior pituitary function in the annexin 1 knockout mouse (2003) (0)
NSAID damage: Mechanism and those at risk (1998) (0)
All the things that aspirin does (2003) (0)
How drugs act (2012) (0)
Pharmacogenetics, pharmacogenomics and ‘personalised medicine’ (2012) (0)
Eicosanoid regulation of ACTH releasein vitro (1995) (0)
Prostaglandin text for physiologists (1978) (0)
Relative Contribution of the Selectins in the Neutrophil Recruitment Caused by the Chemokine Cytokine-Induced Neutrophil Chemoattractant (CINC): Volume221,Number 3 (1996), pages 692–696 (1996) (0)
COX-2-selectivity and the ideal anti-inflammatory (1998) (0)
Enhanced Anti-Inflammatory Effects of Glucocorticoid Receptor Nitration Leads to (2003) (0)
Inflammation during the Resolution Phase of Tissue MonocytesLysophosphatidic Acid To Recruit Definition of a Novel Pathway Centered on Mauro Perretti (2015) (0)
Gustav Born - Bibliography from GUSTAV VICTOR RUDOLPH BORN. 29 July 1921 — 16 April 2018 (2019) (0)
Title : Dysfunctional Skin-Derived Glucocorticoid Synthesis Is a Novel Pathogenic Mechanism of Psoriasis (2017) (0)
In vitro cyclo-oxygenase expression and activity protocols: Introduction to Part I. (2010) (0)
Aspirin's target in anti-inflammatory action (1975) (0)
Consensus and confusion among the Contradas. Molecular and Cellular Biology of IL-1, TNF, and Lipocortins in Inflammation and Differentiation, sponsored by Sclavo Research Center, Siena, Italy, October 22-25, 1989. (1990) (0)
Effect of chronic capsaicin and guanethidine treatment on skin blood flow of the rat (2005) (0)
Inflammatory stimuli modulate the Annexin‐A1 promoter by in human monocytes (2006) (0)
Higher degree of neutrophil activation in vitro and within the microcirculation in absence of annexin 1 (Anx-A1) gene (2005) (0)
Characterization of Gaddum's substance R (1991) (0)
Peptides and proteins as mediators (2007) (0)
Melanocortin agonists possess anti-inflammatory effect in mice with a non-funetional MC1-R (recessive yellow e/e mice) (2003) (0)
On the Eicosanoid Trail with John Vane and Jack McGiff: 1974-1976. A personal reminiscence. (2015) (0)
Investigations intothemechanism ofvasoconstrictor action of thetopical steroid betamethasone-17-valerate intherat (1993) (0)
Rat cytokine-induced neutrophil chemoattractant activates murine neutrophilsin vitro andin vivo (1995) (0)
Cleavage of Annexin‐A1 by Proteinase 3: a possible cause of Wegener’s vasculitis? (2006) (0)
Further studies on the rapid glucocorticoid effects in the U937 monocytic cell line and its potentiation by cromoglycate-like drugs (2008) (0)
INHIBITS LEUKOCYTE ROLLING IN VIVO (2007) (0)
Effect Of Annexin-1 N-Terminal Derived Peptide AC 2-26 On The Acute Phase Of Silicosis In Mice (2011) (0)
Short Title: GR and platelet functions (2016) (0)
Melanocortin Type 3 Receptor on Murine POMC Gene-Derived Peptides Activate (1999) (0)
Introducing prostaglandins (1977) (0)
Localization and signaling of FPR2 in the kidney (2011) (0)
Evidence for an anti-inflammatory loop centred on PMN FPR 2 / ALX and operative in the inflamed microvasculature (2010) (0)
Of lipocortin 1-derived anti-inflammatory active ingredients (1999) (0)
Animal Experiments and the Doctor (2002) (0)
EEffect Of Annexin-1 Derived Peptide Ac2-26 On Allergic Lung Inflammation In Mice (2012) (0)
On the preparation of highly purified slow reacting substance of anaphylaxis (SRS-A) from biological extracts [proceedings]. (1978) (0)
Consensus and confusion among the Contradas (1990) (0)
Melanocortin agonists possess anti-inflammatory effects in mice with a non-functional MC1-R (recessive yellow e/e) (2003) (0)
Annexin A1 - a unique mediator of glucocorticoid action (2005) (0)
Dehydroepiandrosterone steroids are regulators of immune function via leukocyte annexin 1 (2009) (0)
The role of phosphorylation in mediating the annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland (2002) (0)
by using predicted and measured thoracic gas volumes Body composition by air-displacement plethysmography (2015) (0)
5-Hydroxytryptamine and the pharmacology of migraine (2012) (0)
ANTI-ALLERGIC CROMONES INHIBIT HISTAMINE AND EICOSANOID RELEASE FROM HUMAN MAST CELLS THROUGH AN ANNEXIN 1 DEPENDENT MECHANISM (2011) (0)
Oral abstracts 7: Molecular mechanisms of disease—osteoarthritisS1. Identification of novel osteoarthritis genes using zebrafish (2012) (0)
interactions under flow: indication of distinct receptor involvement Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium (2013) (0)
Altered degree of activation and steroid inhibition in leukocytes from annexin 1 null mice (2002) (0)
Modulation of interleukin-1 (IL-1)-induced leukocyte accumulation by both endogenous and exogenous CGRP (1994) (0)
Serumcorticosterone, interleukin- 1andtumournecrosis factor inratexperimental endotoxaemia: comparison between Lewis andWistar strains (1993) (0)
The phospholipase system and the effect of anti-inflammatory glucocorticosteroids (1991) (0)
Influence of Annexin 1 gene deletion on dopaminergic cell numbers in the mid-brain (2003) (0)
Modulation of the receptor ALX/FPR2 in vascular inflammation (2013) (0)
Glucocorticoids as Anti-inflammatory Agents (1982) (0)
Plasma Annexin A1 (AnxA1) is inversely correlated with waist to hip ratio in healthy males (2011) (0)
NSAID use in general practice (1998) (0)
Quantitative Analysis of Promoter Activity by Green Fluorescent Protein (GFP) Target/Reporter Strategy in a Novel Transgenic alx/fpr-rs2 Null Mouse (2009) (0)
Critical protective role for annexin 1 gene expression in mouse endotoxemia (2005) (0)
Fundamentals of Inflammation: Nonsteroidal Anti-Inflammatory Drugs (2010) (0)
Derek Willoughby: A personal reminiscence (2006) (0)
PeritonitisLeukocytes during a Resolving Model of Anti-Inflammatory Gene Expression in Spatial and Temporal Profiles for (2006) (0)
Agonist‐induced conformational change of the Formyl Peptide Receptors (2013) (0)
Biological reagents, processes for their preparation and pharmaceutical formulations containing them (1975) (0)
Annexin A1: a novel target of the immunosuppressive effects of Glucocorticoids in autoimmune diseases (2006) (0)
Formyl Peptide Receptor 2/Lipoxin A Centered on Polymorphonuclear Leukocyte Evidence for an Anti-Inflammatory Loop (2011) (0)
TREATMENT OF autoimmune disease by modulation of annexin 1 (lipocortin 1) (2009) (0)
Annexin 1: a mediator of glucocorticoid action at the neuroendocrine-immune interface. (2006) (0)
New clues in the acetaminophen mystery (2005) (0)
AN OVERVIEW OF THE ROLE OF ANNEXIN-A1 IN ALLERGIC DISEASE (2011) (0)
Prostaglandins and Other Lipid Mediators eview nti-inflammatory drugs , eicosanoids and the annexin A 1 / FPR 2 nti-inflammatory system amia (2011) (0)
Basic principles of antimicrobial chemotherapy (2012) (0)
The role of Formyl peptide receptor 2 (Fpr2) in leukocytes trafficking (2010) (0)
Correction: Lipocortin 1 Mediates Dexamethasone-Induced Growth Arrest of the A459 Lung Adenocarcinoma Cell Line (1992) (0)
New frontiers in the pharmacotherapy of inflammation. (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roderick j. Flower?

Roderick j. Flower is affiliated with the following schools:

Roderick j. Flower's Academic­Influence.com Rankings

Why Is Roderick j. Flower Influential?

Roderick j. Flower's Published Works

Published Works

What Schools Are Affiliated With Roderick j. Flower?

Roderick j. Flower's AcademicInfluence.com Rankings